UNIONDALE, N.Y., April 24, 2025 /PRNewswire/ — PrimeRx, a leading provider of pharmacy management systems, has been recognized at the 2025 American Business Awards® with two major honors: the Silver Stevie® Award for Achievement in Product Innovation and the Bronze Stevie® Award for New Product or Service Introduction of the Year. These wins follow a previous Silver Stevie® received earlier this year in the Customer Service category.
The Silver Stevie® for Achievement in Product Innovation highlights PrimeRx’s transformation into a comprehensive, pharmacy-first technology platform. Over the past year, PrimeRx launched several innovative solutions that address key operational challenges for independent pharmacies:
These innovations allow pharmacies to streamline workflows, cut costs, and improve patient care—all within one connected platform.
The Bronze Stevie® for New Product or Service Introduction of the Year recognizes the successful launch of PrimeRx MARKET and PrimeRx CLOUD, which attracted thousands of pharmacy professionals during the campaign. With these releases, PrimeRx became the first pharmacy software provider to embed real-time purchasing directly into its management system, while also offering flexible cloud-based access.
“This recognition underscores our mission to deliver pharmacy-first innovation that meets today’s needs and anticipates tomorrow’s,” said Ketan Mehta, CEO of PrimeRx. “We’re proud to help independent pharmacies stay efficient, profitable, and patient-focused.”
Since 2024, PrimeRx has expanded from a single product into a full ecosystem that enables independent pharmacies to stay competitive and future-ready. Explore PrimeRx Pharmacy Ecosystem here.
About PrimeRx
PrimeRx provides innovative pharmacy management solutions that improve efficiency, ensure compliance, and enhance patient care. Trusted by thousands of pharmacies nationwide, PrimeRx is redefining the future of pharmacy technology. Learn more at www.PrimeRx.io
Media Contact:
Sylvia Mendoza
VP of Marketing, PrimeRx
smendoza@primerx.io | (516) 408‑399
SOURCE PrimeRx
Black Book Research Q4 flash survey shows health plans shifting from effort-based sourcing to KPI-backed…
CHICAGO, IL / ACCESS Newswire / December 24, 2025 / Healthcare investors have seen this…
$4.1 million upfront with up to approximately $8.3 million of potential additional gross proceeds upon…
The two updates underscore Teva’s strong execution of its Pivot to Growth strategy and commitment…
TORONTO, Dec. 24, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”)…
Purchases reflect strong confidence in the scientific differentiation and commercial potential of ateganosine CHICAGO, Dec.…